Plaintiffs defend US antitrust claims against Celgene, Teva, other over Thalomid, Revlimid
MLex Summary: Plaintiffs opposed Celgene, Teva, AbbVie, and others’ motion to dismiss US claims that they conspired to illegally monopolize the market for Thalomid and Revlimid, saying their amended complaint is...To view the full article, register now.
Already a subscriber? Click here to view full article